LUPI, ALESSIO
 Distribuzione geografica
Continente #
NA - Nord America 934
AS - Asia 435
EU - Europa 298
SA - Sud America 65
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 33
Totale 1.801
Nazione #
US - Stati Uniti d'America 905
SG - Singapore 148
VN - Vietnam 94
CN - Cina 86
IT - Italia 72
RU - Federazione Russa 64
BR - Brasile 50
DE - Germania 39
HK - Hong Kong 33
IE - Irlanda 28
FI - Finlandia 24
CI - Costa d'Avorio 21
SE - Svezia 21
FR - Francia 17
BD - Bangladesh 15
IN - India 15
GB - Regno Unito 14
CA - Canada 13
IQ - Iraq 8
AR - Argentina 6
JP - Giappone 6
HN - Honduras 5
MA - Marocco 5
PH - Filippine 5
PL - Polonia 5
TR - Turchia 5
ID - Indonesia 4
NL - Olanda 4
AZ - Azerbaigian 3
EG - Egitto 3
ES - Italia 3
MX - Messico 3
PK - Pakistan 3
TN - Tunisia 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
BO - Bolivia 2
CO - Colombia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
SA - Arabia Saudita 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
BH - Bahrain 1
CL - Cile 1
DZ - Algeria 1
EU - Europa 1
GP - Guadalupe 1
GR - Grecia 1
IL - Israele 1
LT - Lituania 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
PR - Porto Rico 1
RO - Romania 1
SI - Slovenia 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
Totale 1.769
Città #
Ashburn 202
Singapore 95
San Jose 83
Des Moines 76
Chandler 64
Dallas 35
Council Bluffs 34
Ho Chi Minh City 32
New York 32
Hong Kong 31
Munich 29
Dublin 26
Boardman 25
Los Angeles 23
Abidjan 21
Beijing 20
Hanoi 20
Turku 18
Fairfield 15
Princeton 15
Santa Clara 13
Buffalo 11
Chicago 11
Turin 10
Lauterbourg 9
Moscow 9
The Dalles 9
Rome 8
Hefei 7
Lawrence 7
São Paulo 7
Helsinki 6
Orem 6
Seattle 6
Wilmington 6
Atlanta 5
Da Nang 5
Denver 5
Montreal 5
Phoenix 5
Pune 5
San Mateo 5
Tokyo 5
Urbisaglia 5
Warsaw 5
Washington 5
Arnold 4
Baghdad 4
Boston 4
Brooklyn 4
Clovis 4
Haiphong 4
San Diego 4
Ancona 3
Baku 3
Johannesburg 3
London 3
Mexico City 3
Poplar 3
Rio de Janeiro 3
Salt Lake City 3
Shanghai 3
Sterling 3
Woodbridge 3
Ankara 2
Ann Arbor 2
Bến Tre 2
Cambridge 2
Can Tho 2
City of London 2
Columbus 2
Dhaka 2
El Progreso 2
Fabriano 2
Frankfurt am Main 2
Guangzhou 2
Hải Dương 2
Irvington 2
La Paz 2
Miami 2
Milan 2
Milwaukee 2
New Delhi 2
Ninh Bình 2
Olomouc 2
Philadelphia 2
Porto Alegre 2
Roubaix 2
Stockholm 2
Tashkent 2
Tiền Hải 2
Toronto 2
Wuhan 2
Acalanes Ridge 1
Agadir 1
Al Mansurah 1
Andover 1
Aryanah 1
Asyut 1
Bacoor 1
Totale 1.202
Nome #
Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer 190
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab 169
Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with immunotherapy: a single center, retrospective, real-world analysis 162
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 154
Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study 153
Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer 151
Seroprevalence of SARS-CoV-2-Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy 139
Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab 135
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment 133
The Landscape of ALK-Rearranged Non-Small Cell Lung Cancer: A Comprehensive Review of Clinicopathologic, Genomic Characteristics, and Therapeutic Perspectives 122
Current Evidence and Future Perspectives about the Role of PARP Inhibitors in the Treatment of Thoracic Cancers 110
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study 100
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study 83
Totale 1.801
Categoria #
all - tutte 7.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.994


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202254 0 0 0 3 0 5 1 0 14 2 14 15
2022/2023232 13 23 8 15 6 90 0 9 35 6 24 3
2023/2024126 19 4 8 6 16 50 1 3 0 4 1 14
2024/2025272 44 23 4 9 14 13 9 7 43 13 47 46
2025/2026919 73 47 43 98 119 66 163 78 77 88 46 21
2026/2027170 45 36 24 65 0 0 0 0 0 0 0 0
Totale 1.801